Wedbush reaffirmed their outperform rating on shares of Beam Therapeutics (NASDAQ:BEAM – Free Report) in a research report released on Monday morning,RTT News reports. They currently have a $57.00 target price on the stock. Several other equities research analysts also recently commented on the company. Leerink Partnrs raised Beam Therapeutics from a “hold” rating to […]

AnaptysBio (NASDAQ:ANAB – Get Free Report)‘s stock had its “outperform” rating reaffirmed by equities research analysts at Wedbush in a note issued to investors on Wednesday,RTT News reports. They currently have a $40.00 price objective on the biotechnology company’s stock, down from their prior price objective of $42.00. Wedbush’s price objective would suggest a potential […]

Sutro Biopharma (NASDAQ:STRO – Get Free Report)‘s stock had its “market outperform” rating restated by equities research analysts at JMP Securities in a research report issued on Wednesday,Benzinga reports. They currently have a $17.00 price objective on the stock. Other analysts have also issued research reports about the company. Truist Financial lowered their target price […]